/Investor DB

Sante Ventures — Full Portfolio

20 tracked investments · listed companies and verified rows first

Aimbientaimbient.comin𝕏Series A · May 2023 · $15M

Aimbient builds an ambient AI platform for procedural medicine that automatically captures clinical cases and generates actionable intelligence for healthcare teams to improve patient care and operational outcomes.

AI & Machine LearningHealthtechMedical DevicesNew York, US

Co-investorsUS Venture Partners

BAROnova, Inc.baronova.cominSeries C · Feb 2013 · $27M

Non-surgical, non-pharmacologic devices to induce weight loss

Co-investorsDelos CapitalLongitude CapitalArboretum VenturesHighland Capital Partners

BeeKeeperAIbeekeeperai.comin𝕏Series A · Jun 2023 · $12.1M

BeeKeeperAI enables healthcare AI developers and researchers to access diverse, real-world clinical data while keeping it secure within private cloud infrastructure.

AI & Machine LearningCybersecurityData & InfrastructureDigital HealthHealthtech

Co-investorsAIX Ventures

Clairityclairitytech.comSeries B · Nov 2025 · $43M

Clairity develops direct air capture and mineralization technology to remove carbon dioxide from the atmosphere.

CleantechClimate TechDeep TechHealthtechSouthern Nevada, US

Glen Meyerowitz(Founder)

BoardJoe Cunningham(Director)Kevin Lalande(Executive Officer, Director)

Co-investorsInitialized CapitalLowercarbon CapitalSante Health Ventures

Claret Medicalclaretmedical.comOct 2017

HealthtechSanta Rosa, US

Fred Khosravi(Director)Tony Fields(Executive Officer)

BoardJames Eadie(Director)Azin Parhizgar(Executive Officer, Director)inHenry A. Plain(Director)Leo Nelson Hopkins(Director)

Co-investors415 CapitalLightstone VenturesEaston CapitalMorgenthaler

Endostimendostim.comin𝕏Series B · Jul 2010 · $6M

EndoStim develops a neurostimulation medical device system for treating drug-resistant gastroesophageal reflux disease (GERD) by restoring esophageal function while preserving normal anatomy.

BiotechHealthtechMedical DevicesSt. Louis, US

Eric Goorno(Chief Executive Officer)Greg Wilson(Chief Financial Officer)Stephen Attwood, MD(Surgical Director)Virender Sharma, MD(Chief Medical Officer)Hazim Ansari(Chief Legal Counsel)Bevil J. Hogg(Executive Officer, Director)

Co-investorsRelevance Ventures

kelaHealthkelahealth.comin𝕏Seed · Oct 2020 · $3M

KelaHealth develops data-driven solutions that apply insights from millions of patient records to personalize and improve medical decision-making.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechMedical DevicesSan Francisco, US

Bora Chang(Executive Officer, Director)

BoardDennis McWilliams(Director)

Co-investorsBlue Hour VenturesIntuitive VenturesNC IDEANueterra CapitalTechstars

Lumos Pharmalumos-pharma.comin𝕏Series A · Apr 2016 · $14M

Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.

BiotechHealthtechAustin, US

Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in

Co-investorsNew Enterprise Associates (NEA)Roche Venture FundClarus VenturesDeerfield Management CompanySante Health VenturesWellcome Trust

OutcomesAIoutcomes.aiin𝕏Seed · Oct 2025 · $10M

OutcomesAI combines AI voice agents with licensed nurses to deliver scalable, high-quality care across hospitals, virtual care, and specialty programs.

AI & Machine LearningDigital HealthHealthtech

Kuldeep Singh Rajput(Founder)

Co-investorsHeadwater Ventures

RapidPulserapidpulsemed.comSeries A · Jun 2021 · $15M

RapidPulse Medical is an investor relations page showcasing multiple healthcare-focused investment firms and incubators that back medical device and healthcare technology companies.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsBroadview VenturesEpidarex CapitalFlorida Opportunity FundHatteras Venture PartnersS3 Ventures

Reimagine Carereimaginecare.cominSeries A · Jan 2022 · $25M

Reimagine Care partners with cancer providers and health systems to deliver virtual oncology care combining AI-powered support, clinical expertise, and digital monitoring to manage symptoms, reduce emergency visits, and improve patient outcomes outside the clinic setting.

AI & Machine LearningDigital HealthHealthtechNashville, US

Dan Nardi(Mr. Nardi is the CEO and a director of the Issuer)Keith Figlioli(Director)Feby Abraham(Director)Chris Stenzel(Director)

BoardDouglas French(Director)Harlan Levine(Director)in

Co-investorsCU Healthcare Innovation FundFirst Trust Capital PartnersLRVHealthMartin VenturesMcKesson VenturesOncology Ventures

Reprieve Cardiovascularreprievecardio.com

Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients.

Digital HealthHealthtechMedical DevicesMilford, US

Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)inMark Pacyna(Executive Officer, Director)inJim Dillon(Executive Officer, Director)Hanson S. Gifford III(Director)Gregory W Mann(Executive Officer)

Co-investorsArboretum VenturesLightstone VenturesRex Health VenturesDeerfield Management CompanyGenesis Venture Capital

Sensorium Therapeuticssensorium.bioinSeries A · Oct 2022 · $30M

Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.

AI & Machine LearningBiotechDigital HealthMedford, US

Jerrold Rosenbaum(Co-Founder & Chair Emeritus, Massachusetts General Hospital (MGH) Department of Psychiatry)inJacob Hooker(Co-Founder & Chief Executive Officer)inPranav Tadi(Executive Officer)Stephen Haggarty, PhD(Co-Founder & Professor of Neurology, Harvard Medical School)Dick Simon, MBA(Co-Founder)

BoardRyan Katz(Director)in

Co-investorsBonaventure Equity, LLCCU Healthcare Innovation FundDolby Family VenturesHatteras Venture PartnersIter InvestmentsMission Biocapital+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

DyaMXbeHuman HealthBradoNirogy TherapeuticsRiseHealthSONIRE TherapeuticsTerapio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.